Meeting
2023 ASCO Genitourinary Cancers Symposium
Role of adenomatous polyposis coli (APC) gene in SPOP-mutant prostate cancer and clinical outcomes.
Authors
Shamis Khan
Baylor College of Medicine, Houston, TX
Shamis Khan , Heidi Dowst , Quillan Huang , Attiya Batool Noor , Guilherme Godoy , Neda Zarrin-Khameh , Patricia Castro , Michael E. Scheurer , Susan G. Hilsenbeck , Martha P. Mims , Nicholas Mitsiades
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 202)
DOI
10.1200/JCO.2023.41.6_suppl.202
Abstract #
202
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Associations between sarcopenia and clinical outcomes in men with metastatic castrate-resistant prostate cancer.
First Author: Efthymios Papadopoulos
Poster
2023 ASCO Annual Meeting
Early results from CASCARA: A phase 2 study of cabazitaxel/carboplatin plus abiraterone in high-volume metastatic castrate-sensitive prostate cancer (mCSPC).
First Author: Charles J. Ryan
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
First Author: Minas P. Economides
Poster
2022 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
First Author: Minas P. Economides